1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 461-470 of 579 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013A no-prophylaxis platelet-transfusion strategy for hematologic cancersStanworth, S.; Estcourt, L.; Powter, G.; Kahan, B.; Dyer, C.; Choo, L.; Bakrania, L.; Llewelyn, C.; Littlewood, T.; Soutar, R.; Norfolk, D.; Copplestone, A.; Smith, N.; Kerr, P.; Jones, G.; Raj, K.; Westerman, D.; Szer, J.; Jackson, N.; Bardy, P.; et al.
2017New monoclonal antibodies to defined cell surface proteins on human pluripotent stem cellsO’Brien, C.M.; Chy, H.S.; Zhou, Q.; Blumenfeld, S.; Lambshead, J.W.; Liu, X.; Kie, J.; Capaldo, B.D.; Chung, T.L.; Adams, T.E.; Phan, T.; Bentley, J.D.; McKinstry, W.J.; Oliva, K.; McMurrick, P.J.; Wang, Y.C.; Rossello, F.J.; Lindeman, G.J.; Chen, D.; Jarde, T.; et al.
2017Inflammation-induced IgA⁺ cells dismantle anti-liver cancer immunityShalapour, S.; Lin, X.-J.; Bastian, I.N.; Brain, J.; Burt, A.D.; Aksenov, A.A.; Vrbanac, A.F.; Li, W.; Perkins, A.; Matsutani, T.; Zhong, Z.; Dhar, D.; Navas-Molina, J.A.; Xu, J.; Loomba, R.; Downes, M.; Yu, R.T.; Evans, R.M.; Dorrestein, P.C.; Knight, R.; et al.
2017Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)McElvaney, N.; Burdon, J.; Holmes, M.; Glanville, A.; Wark, P.; Thompson, P.; Hernandez, P.; Chlumsky, J.; Teschler, H.; Ficker, J.; Seersholm, N.; Altraja, A.; Mäkitaro, R.; Chorostowska-Wynimko, J.; Sanak, M.; Stoicescu, P.; Piitulainen, E.; Vit, O.; Wencker, M.; Tortorici, M.; et al.
2013Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney diseaseDe Zeeuw, D.; Akizawa, T.; Audhya, P.; Bakris, G.; Chin, M.; Christ-Schmidt, H.; Goldsberry, A.; Houser, M.; Krauth, M.; Lambers Heerspink, H.; McMurray, J.; Meyer, C.; Parving, H.; Remuzzi, G.; Toto, R.; Vaziri, N.; Wanner, C.; Wittes, J.; Wrolstad, D.; Chertow, G.; et al.
2019Inhibition of Upf2-dependent nonsense-mediated decay leads to behavioral and neurophysiological abnormalities by activating the immune responseJohnson, J.L.; Stoica, L.; Liu, Y.; Zhu, P.J.; Bhattacharya, A.; Buffington, S.; Huq, R.; Eissa, N.T.; Larsson, O.; Porse, B.T.; Domingo, D.; Nawaz, U.; Carroll, R.; Jolly, L.; Scerri, T.S.; Kim, H.-G.; Brignell, A.; Coleman, M.J.; Braden, R.; Kini, U.; et al.
2015Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis CAlavi, M.; Spelman, T.; Matthews, G.V.; Haber, P.S.; Day, C.; van Beek, I.; Walsh, N.; Yeung, B.; Bruneau, J.; Petoumenos, K.; Dolan, K.; Kaldor, J.M.; Dore, G.J.; Hellard, M.; Grebely, J.; Marks, P.; Amin, J.; Doab, A.; Carroll, T.; Teutsch, S.; et al.
2018Mutations in the epithelial cadherin-p120-catenin complex cause Mendelian non-syndromic cleft lip with or without cleft palateCox, L.; Cox, T.; Moreno Uribe, L.; Zhu, Y.; Richter, C.; Nidey, N.; Standley, J.; Deng, M.; Blue, E.; Chong, J.; Yang, Y.; Carstens, R.; Anand, D.; Lachke, S.; Smith, J.; Dorschner, M.; Bedell, B.; Kirk, E.; Hing, A.; Venselaar, H.; et al.
2018Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk diseaseBranford, S.; Wang, P.; Yeung, D.T.; Thomson, D.; Purins, A.; Wadham, C.; Shahrin, N.H.; Marum, J.E.; Nataren, N.; Parker, W.T.; Geoghegan, J.; Feng, J.; Shanmuganathan, N.; Mueller, M.C.; Dietz, C.; Stangl, D.; Donaldson, Z.; Altamura, H.; Georgievski, J.; Braley, J.; et al.
2014Nursing home research: the first international association of gerontology and geriatrics (IAGG) research conferenceRolland, Y.; Resnick, B.; Katz, P.R.; Little, M.O.; Ouslander, J.G.; Bonner, A.; Geary, C.R.; Schumacher, K.L.; Thompson, S.; Martin, F.C.; Wilbers, J.; Zúñiga, F.; Ausserhofer, D.; Schwendimann, R.; Schüssler, S.; Dassen, T.; Lohrmann, C.; Levy, C.; Whitfield, E.; de Souto Barreto, P.; et al.

Discover